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DISCOVERY OF POTENT MMP-13 SPECIFIC INHIBITOR
WITHOUT MUSCULOSKELETAL SIDE EFFECTS
D. Piecha1, V. Baragi2, A. Jaworski1, B. Korniski2, D. Nix2,
T. Powers2, C. Steeneck1, A. Taveras2, J. VanVelduizen2,
J. Weik1, M. Hofmann1
1Alantos Pharmaceuticals, Heidelberg, Germany, 2Alantos
Pharmaceuticals, Cambridge, MA
Purpose: Broad-spectrum MMP inhibitors have shown efficacy
in a variety of animal models of osteoarthritis (OA) and in-
flammation. However the clinical utility of these inhibitors has
been restricted by musculoskeletal side effects (MSS). While the
mechanism of this toxicity remains unclear, it has been reported
that non-selective inhibition of multiple MMPs may be responsible
for the observed toxicities. MMP-13 being the most potent type II
collagenase, is highly up-regulated in OA/RA and is responsible
for the degradation of human cartilage. Therefore selective inhi-
bition of MMP-13 may provide the desired cartilage degradation
protection needed for potential treatment of OA while overcoming
the MSS toxicity seen by non-selective inhibition of MMPs.
Methods: Cartilage penetration and extraction. Rat model of
MSS.
Results: We have identified a new class of potent, highly selec-
tive, non-zinc-binding MMP-13 inhibitors with excellent efficacy
in an in vitro cartilage degradation assay (data shown in sec-
ond poster). In vitro penetration experiments showed that these
inhibitors penetrated and accumulated in the cartilage while in
vivo studies with ALS 1-0635 demonstrated excellent oral avail-
ability and effective penetration into rat cartilage. Furthermore,
rats treated with ALS 1-0635 (100 mg/kg/day, p.o.) did not exhibit
musculoskeletal side-effects in the 14-day rat model of MSS and
showed no signs of clinical or histological changes characteristic
of musculoskeletal toxicity. While the positive control compound,
marimastat, a broad-spectrum MMP inhibitor, caused significant
toxicity (6.25 mg/kg/day dosed i.p. via Alzet pump) characterized
by soft tissue and bone changes, increased epiphyseal growth
plate, synovial hyperplasia and increased cellularity in the joint
capsule.
Conclusions: Our highly selective MMP-13 inhibitors repre-
sent a new class of orally bioavailable, cartilage-penetrating
compounds for the potential treatment of osteoarthritis without
the musculoskeletal toxicities that have plagued early MMP in-
hibitors.
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LONG-LASTING ANALGESIC EFFECT OF
INTRA-ARTICULAR INJECTION OF CROSS-LINKED
HYALURONATE GEL (GEL-200) ON ARTHRITIC PAIN
K. Yoshioka, K. Miyamoto, R. Abe, Y. Yasuda, N. Oshima,
H. Maruyama
Central Research Laboratories, Seikagaku Corporation, Tokyo,
Japan
Purpose: The objective of this study was to examine the long-
lasting analgesic effect and local retention of intra-articularly
injected cross-linked hyaluronate hydrogel (Gel-200), which has
been developed as a novel therapeutic agent for the knee os-
teoarthritis (OA).
Methods: 1) Determining the effects of Gel-200 on the
bradykinin-induced arthritic pain.
Gel-200, physiological saline or SUPARTZ® was administered
into the knee joint cavity of the left hind leg of female rats at a
dose of 0.05 mL/joint. On weeks 1, 2 and 4 after administration,
bradykinin (an endogenous hyperalgesic substance) with PGE2
(a pain enhancer) solutions were injected into the same joint
to induce arthritic pain. SUPARTZ® was only evaluated at 1
week, since this treatment typically requires reinjection once
a week. Under blinded conditions, the walking of the animal
was observed for about 2 minutes after injection of bradykinin
solutions and severity of pain was scored on a 5-point scale.
2) Determining the residual ratio of Gel-200 in joint cavity and
synovium of the knee in rabbits.
Gel-200 and its non-cross-linked intermediate (h-HAD), which
had same cross-linked agent as Gel-200, were administered into
the knee joint cavity in male rabbits at a dose of 0.05 mL/kg/joint.
Animals were sacrificed on days 1, 3, 5, 7, 14 and 28 after
administration, and synovial fluid and synovium were collected.
The common cross-linked agent of Gel-200 was quantified by
high performance liquid chromatography (HPLC) to calculate the
residual ratios of Gel-200 and h-HAD.
Results: 1) Gel-200 significantly suppressed the bradykinin-
induced pain response compared with control group at the time
points 1, 2 and 4 weeks post administration. The analgesic effect
by Gel-200 was more remarkable than that by SUPARTZ® at 1
week.
2) Most of Gel-200 disappeared from the synovial fluid within 7
days, however, it remained in the synovium for up to 28 days after
administration. By comparing the residual ratios of Gel-200 and
h-HAD, significantly higher levels of Gel-200 were detected in the
synovial fluid on days 1, 3 and 5 after administration. However, in
the synovium, the ratios of Gel-200 remained significantly higher
on days 7, 14, and 28. The results with h-HAD were similar to
those reported previously using 14C-hyaluronan.
Conclusions: It was demonstrated that Gel-200 administered
into the joint cavity was more effective against the arthritic pain
than SUPARTZ® and provided a sustained analgesic effect lasted
for at least 4 weeks. Furthermore, compared to non-cross-linked
hyaluronan, the injected Gel-200 remained in synovial fluid and
synovium for a prolonged period of time. Consequently, since
Gel-200 remains in the joint cavity longer, and is incorporated
into the synovium slowly, it is speculated that Gel-200 exerts a
long-lasting analgesic effect.
P62
ANALGESIC EFFECT OF CROSS-LINKED
HYALURONATE HYDROGEL (GEL-200) ON THE
MONOSODIUM URATE-INDUCED ARTHRITIC JOINT PAIN
IN DOGS
K. Takahashi, K. Yoshioka, K. Miyamoto, H. Maruyama
Central Research Laboratories, Seikagaku Corporation, Tokyo,
Japan
Purpose: The deposit of micro-crystals of monosodium urate
(MSU) in synovial fluid promotes acute inflammatory joint pain
in humans. The experimental joint pain model induced by an
intra-articular injection of MSU crystals has been widely used
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to evaluate the analgesic effect of sodium hyaluronate and non-
steroidal anti-inflammatory drugs.
The objective of this study was to examine the analgesic effect
of cross-linked hyaluronate hydrogel (Gel-200), which has been
developed as a novel therapeutic agent for the knee OA, on joint
pain induced by MSU in dogs.
Methods: Gel-200, physiological saline or sodium hyaluronate
(HA) was administered to female beagle dogs by an intra-articular
injection into the knee joint cavity of the left hind limb at a dose
of 0.3 mL/kg/joint. Monosodium urate (MSU), a substance which
induces inflammation and severe pain, was then injected at the
same joint 0.5 or 72 hours after the test material treatment. At 2,
3, 4, 5, 6 and 8 hours after the injection of MSU, gait condition
was scored and weight-bearing rates of the left hind limb were
calculated as the joint pain indicators. The area under the time
curve (AUC) was calculated from both these indicators.
Results: In experiments where MSU was injected 0.5 hour after
the test material treatment, the mean AUCs of abnormal gait
score were 0.0, 28.0 and 13.5 in Gel-200, physiological saline
and HA, respectively. Gel-200 exhibited a complete analgesic
effect and no painful walking was observed in all of the treated
animals. HA also exhibited a significant analgesic effect, as
compared to physiological saline, but the effect was significantly
lower than that of Gel-200.
In experiments where MSU was injected 72 hours after the
test material treatment, the AUCs of abnormal gait score were
1.5, 27.6 and 27.1 in Gel-200, physiological saline and HA,
respectively. Gel-200 still exhibited a significant analgesic effect,
whereas the effect of HA on the knee joint pain was almost
completely diminished.
In both the experiments, changes in the weight-bearing rates of
the left hind limb were consistent with those of the abnormal gait
scores.
Conclusions: It was confirmed that the single intra-articular
administration of Gel-200 suppressed the MSU-induced arthritic
knee joint pain. Compared to HA, the analgesic effect of Gel-200
was superior and more prolonged.
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GAIT AS A MEASURE OF PAIN AND FUNCTIONAL
DISABILITY IN THE CANINE GROOVE MODEL OF
OSTEOARTHRITIS
L.N. Frost-Christensen1, S.C. Mastbergen2, M.E. Vianen2,
A. van Wees1, K.M. Jacobs2, F.P. Lafeber2, H.A. Hazewinkel1
1Utrecht University, Utrecht, The Netherlands, 2University
Medical Center Utrecht, Utrecht, The Netherlands
Purpose: For the canine Groove model of osteoarthritis, end-
point measures of structural changes in cartilage, bone and
synovial tissue have been described for the Beagle dog. In
the present study longitudinal evaluation of gait as a surrogate
marker of pain and functional disability has been evaluated in
this model in the Labrador retriever in addition to osteophytosis
and the cartilage endpoint parameters.
Methods: Knee osteoarthritis was induced in 7 Labrador re-
trievers according to the Groove model. Each four weeks radio-
graphs were taken to analyze for osteophyte formation and each
two weeks gait was recorded using force plate analysis. At 12
weeks animals were euthanized and cartilage matrix proteogly-
can turnover was analyzed for features of osteoarthritis.
Results: After 12 weeks, induction of osteoarthritis in the
Labrador Groove model resulted in histological cartilage dam-
age, changes in cartilage proteoglycan turnover, loss of carti-
lage matrix proteoglycans, and slight synovial inflammation, all
characteristics of early osteoarthritis and similar to those previ-
ously observed in the Beagle. Moreover, radiographic evaluation
showed a progressive increase in osteophyte formation. There
was a decrease in peak braking, stance, and propelling force
in the osteoarthritic leg. This was the most obvious in the first
weeks after surgical induction of osteoarthritis, gradually improv-
ing, but remaining decreased for up to 12 weeks. No changes
were seen in the loading pattern of the other three legs. Most
interestingly, using an extended group of Labrador retrievers with
experimentally induced osteoarthritis, the decrease in loading of
the experimental leg during development of osteoarthritis cor-
related with the decrease in cartilage integrity as an endpoint
parameter.
Conclusions: The Groove model is applicable for the Labrador
retriever as an experimental model of osteoarthritis and gait
analysis might be used as a surrogate marker for pain and func-
tional disability. Most important, the degree of cartilage damage
is reflected by the extent to which the osteoarthritic joint was
unloaded.
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CHARACTERISATION OF TEMPORAL CHANGES OF
AGGRECANASE-DEPENDANT PROTEOGLYCAN LOSS IN
THE GUINEA PIG MODEL OF SPONTANEOUS OA
J.K. Flannelly, C.L. Day, S.J. Read, J. Bowyer
In Vivo Pharmacology, Respiratory & Inflammation,
Astrazeneca, Macclesfield, Cheshire, United Kingdom
Purpose: The aim of this work was to characterise tempo-
ral changes of aggrecan-specific fragments (NITEGE 373 neo-
epitope) in the Dunkin Hartley guinea pig model of OA. Changes
were investigated in the medial and lateral tibial cartilage com-
partments and synovial fluid lavages using dot blot immunoassay
and a cleavage site-specific antibody.
Methods: Synovial lavages using 0.05M EDTA solution (100μl)
and articular cartilage dissected from the lateral and medial tibial
plateau compartments were taken from hind knee joints of male
Dunkin Hartley guinea pigs, aged 3, 4, 6, 9, 12 and 18 months
(n=5/per time point).
Aggrecan specific fragments were detected in cartilage extracts
(500mM NaCl, 25mM Tris pH 7.5 overnight @4°C) and synovial
lavages by dot blot immunoassay using a cleavage site-specific
antibody RAM 3-2 (raised against the aggrecanase-generated
G1 fragment terminating in NITEGE 373). ECL detection followed
by film exposure allowed quantification of protein by densitom-
etry using a Biorad densitometer. Total sulphated glycosamino-
glycans (sGAG) remaining in the cartilage were liberated using
papain digestion (0.125mg/mL, 4 hours at 60°C) and measured
using 1,9-dimethylmethylene blue (DMMB) dye binding, this was
added to sGAG measured in the extract to obtain total GAG in
cartilage
Results: Total sGAG levels were similar across the time-course
relative to weight of cartilage. The NITEGE 373 neo-epitope
fragments measured in the tibial cartilage extracts increased as
Fig. 1. Temporal profile of NITEGE fragment in Guinea Pig Medial and Lateral
tibial articular cartilage. Data represents mean ± Standard error of the mean.
